Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lirong Liu

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 6, 2019
Selective inhibition of class IIa histone deacetylases alleviates renal fibrosisChongxiang Xiong, Yingjie Guan, Xiaoxu Zhou, et al.
Scientific Reports|November 16, 2024
A novel role of peroxiredoxin 2 in diabetic kidney disease progression by activating the classically activated macrophagesXia Li, Hehua Long, Rui Peng, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|November 6, 2018
[Development and verification of reference nucleic acid materials of H9N2 influenza viruses by real-time RT-PCR]Jie Song, Cui Li, Jing Li, et al.
Iscience|February 2, 2024
Investigating HMGB1 as a potential serum biomarker for early diabetic nephropathy monitoring by quantitative proteomicsRui Peng, Siyang Zuo, Xia Li, et al.
Experimental Cell Research|October 1, 2021
SAA1 is transcriptionally activated by STAT3 and accelerates renal interstitial fibrosis by inducing endoplasmic reticulum stressFan Zhang, Xingcheng Zhou, Huimei Zou, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 20, 2025
SMYD2 Promotes Renal Tubular Cell Apoptosis and Chronic Kidney Disease Following Cisplatin NephrotoxicitySiyang Zuo, Huixiong Yuan, Xia Li, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Discovery of Hepatotoxic Equivalent Markers and Mechanism of <i>Polygonum multiflorum</i> Thunb. by Metabolomics Coupled with Molecular DockingYinhuan Zhang, Lirong Liu, Menghan Feng, et al.
Frontiers in Pharmacology|March 23, 2023
Polygoni Multiflori Radix interferes with bile acid metabolism homeostasis by inhibiting <i>Fxr</i> transcription, leading to cholestasisYihang Dai, Zhixin Jia, Cong Fang, et al.
Journal of Pharmacological Sciences|July 31, 2023
Pharmacological inhibition of SMYD2 protects against cisplatin-induced renal fibrosis and inflammationMin Chen, Siyang Zuo, Siyu Chen, et al.
Experimental and Molecular Pathology|January 10, 2020
Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoNYuanyuan Wang, Xiaohuan Zhang, Yanwen Mao, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 6, 2019
Selective inhibition of class IIa histone deacetylases alleviates renal fibrosisChongxiang Xiong, Yingjie Guan, Xiaoxu Zhou, et al.
Scientific Reports|November 16, 2024
A novel role of peroxiredoxin 2 in diabetic kidney disease progression by activating the classically activated macrophagesXia Li, Hehua Long, Rui Peng, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|November 6, 2018
[Development and verification of reference nucleic acid materials of H9N2 influenza viruses by real-time RT-PCR]Jie Song, Cui Li, Jing Li, et al.
Iscience|February 2, 2024
Investigating HMGB1 as a potential serum biomarker for early diabetic nephropathy monitoring by quantitative proteomicsRui Peng, Siyang Zuo, Xia Li, et al.
Experimental Cell Research|October 1, 2021
SAA1 is transcriptionally activated by STAT3 and accelerates renal interstitial fibrosis by inducing endoplasmic reticulum stressFan Zhang, Xingcheng Zhou, Huimei Zou, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 20, 2025
SMYD2 Promotes Renal Tubular Cell Apoptosis and Chronic Kidney Disease Following Cisplatin NephrotoxicitySiyang Zuo, Huixiong Yuan, Xia Li, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Discovery of Hepatotoxic Equivalent Markers and Mechanism of <i>Polygonum multiflorum</i> Thunb. by Metabolomics Coupled with Molecular DockingYinhuan Zhang, Lirong Liu, Menghan Feng, et al.
Frontiers in Pharmacology|March 23, 2023
Polygoni Multiflori Radix interferes with bile acid metabolism homeostasis by inhibiting <i>Fxr</i> transcription, leading to cholestasisYihang Dai, Zhixin Jia, Cong Fang, et al.
Journal of Pharmacological Sciences|July 31, 2023
Pharmacological inhibition of SMYD2 protects against cisplatin-induced renal fibrosis and inflammationMin Chen, Siyang Zuo, Siyu Chen, et al.
Experimental and Molecular Pathology|January 10, 2020
Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoNYuanyuan Wang, Xiaohuan Zhang, Yanwen Mao, et al.
Pageof 17